In short
Cisplatin is a powerful chemotherapy drug being studied in various clinical trials for its effectiveness in treating different types of cancer. These trials aim to evaluate cisplatin's efficacy when used alone or in combination with other drugs, as well as to determine optimal dosing strategies and potential side effects. The research spans multiple cancer types, including pancreatic, gastric, lung, and bladder cancers, among others.
At a glance
- Cancer Types Studied
- Pancreatic, Gastric, Lung, Bladder, Esophageal, Cervical, Neuroendocrine
- Common Drug Combinations
- Gemcitabine, Pemetrexed, Docetaxel, 5-Fluorouracil, Sorafenib, Panitumumab, Everolimus
- Administration Methods
- Intravenous, various dosing schedules (e.g., split-dose, weekly)
- Primary Outcomes Measured
- Progression-free survival, Overall survival, Objective response rate, Disease control rate
- Secondary Outcomes
- Duration of response, Time to progression, Safety profile, Quality of life
- Exploratory Objectives
- Biomarker identification, Predictive factors for efficacy/safety
Introduction
Cisplatin is a powerful chemotherapy drug used to treat various types of cancer. It is known by the chemical name cis-diamminedichloroplatinum(II) and sometimes referred to by the abbreviation CDDP. Cisplatin has been used in cancer treatment for decades and remains an important tool in fighting many aggressive cancers.
How Cisplatin Works
Cisplatin works by damaging the DNA in cancer cells, which prevents them from dividing and growing. This eventually leads to the death of cancer cells. As a platinum-based chemotherapy drug, cisplatin is very effective at killing rapidly dividing cells like those found in tumors.
Cancers Treated with Cisplatin
Cisplatin is used to treat several types of cancer, including:
- Head and neck cancers
- Cervical cancer
- Bladder cancer
- Esophageal cancer
It is often combined with other chemotherapy drugs or radiation therapy for maximum effectiveness in treating these aggressive cancers.
How Cisplatin is Administered
Cisplatin is typically given intravenously (through an IV) in a hospital or clinic setting. The dose and schedule can vary depending on the type of cancer and treatment plan. Some common administration methods include:
- Weekly doses of 40 mg/m2
- Larger doses of 75 mg/m2 every 3 weeks
- 60 mg/m2 combined with other chemotherapy drugs
Patients usually receive cisplatin treatment in cycles, with rest periods in between to allow the body to recover.
Side Effects and Precautions
While cisplatin is effective against cancer, it can also cause significant side effects. Some common side effects include:
- Nausea and vomiting
- Kidney damage
- Hearing loss and tinnitus (ringing in the ears)
- Nerve damage (neuropathy)
- Decreased blood cell counts
To help manage these side effects, patients are often given additional medications and fluids. Doctors closely monitor kidney function and hearing throughout treatment.
Ongoing Research
Researchers continue to study ways to improve cisplatin treatment and reduce its side effects. Some current areas of research include:
- Combining cisplatin with newer targeted therapies
- Using cisplatin before surgery (neoadjuvant therapy) in bladder cancer
- Exploring ways to protect hearing, such as intratympanic steroid injections
- Testing cisplatin in combination with other drugs for esophageal cancer
Frequently Asked Questions
How long does cisplatin treatment usually last?
The duration of cisplatin treatment varies depending on the type and stage of cancer. Typically, patients receive multiple cycles of treatment over several months. Each cycle may last 3-4 weeks, with treatment given on specific days followed by a rest period.
Can cisplatin be used for all types of cancer?
While cisplatin is effective against many types of cancer, it is not used for all cancers. It is most commonly used for solid tumors, particularly those affecting the head and neck, lungs, ovaries, testicles, bladder, and cervix. Your oncologist will determine if cisplatin is appropriate for your specific type and stage of cancer.
Are there ways to reduce the risk of hearing loss from cisplatin?
Researchers are actively studying methods to protect hearing during cisplatin treatment. One approach being investigated is the use of intratympanic steroid injections, where steroids are injected directly into the middle ear to potentially protect the inner ear from damage. However, this is still experimental and not yet standard practice. It's important to discuss any concerns about hearing loss with your healthcare team.
Summary
| Aspect | Details |
|---|---|
| Drug Name | Cisplatin (CDDP) |
| Type | Platinum-based chemotherapy |
| Main Uses | Head and neck, cervical, bladder, esophageal cancers |
| Administration | Intravenous (IV), various dosing schedules |
| Key Side Effects | Nausea, kidney damage, hearing loss, nerve damage |
| Current Research | Combination therapies, side effect reduction, new applications |
Glossary
- Chemotherapy - The use of drugs to destroy cancer cells
- Platinum-based - A class of chemotherapy drugs that contain platinum
- Neoadjuvant therapy - Treatment given before the main treatment, usually to shrink a tumor
- Intratympanic - Delivered into the middle ear
- Tinnitus - A ringing or buzzing noise in one or both ears